University of Southern California, Los Angeles, CA, USA.
North American Association of Central Cancer Registries, Springfield, IL, USA.
J Natl Cancer Inst Monogr. 2024 Aug 1;2024(65):191-197. doi: 10.1093/jncimonographs/lgae005.
The National Cancer Institute funds many large cohort studies that rely on self-reported cancer data requiring medical record validation. This is labor intensive, costly, and prone to underreporting or misreporting of cancer and disparity-related differential response. US population-based central cancer registries identify incident cancer within their catchment area, yielding all malignant neoplasms and benign brain and central nervous system tumors with standardized data fields. This manuscript describes the development, implementation, and features of a system to facilitate linkage between cohort studies and cancer registries and the release of cancer registry data for matched cohort participants.
The Virtual Pooled Registry-Cancer Linkage System (VPR-CLS) provides an online system to link cohorts with multiple state cancer registries by 1) securely transmitting a study file to registries, 2) providing an optimized linkage algorithm to generate preliminary match counts, and 3) providing a streamlined process and templated forms for submitting and tracking data requests for cohort participants who matched with registries.
In 2022, the VPR-CLS launched with 45 registries, covering 95% of the US state populations and Puerto Rico. Registries have linked with 15 studies having 14 273-10.9 million participants. Except in 1 study, linkage sensitivity ranged from 87.0% to 99.9%. Numerous registries have adopted the VPR-CLS templated institutional review board-registry application (n = 39), templated data use agreement (n = 25), and central institutional review board (n = 16).
The VPR-CLS markedly improves ascertainment of cancer outcomes and is the preferred approach for determination of outcomes from cohort studies, postmarketing surveillance, and clinical trials.
美国国家癌症研究所资助了许多大型队列研究,这些研究依赖于自我报告的癌症数据,需要对医疗记录进行验证。这是一项劳动密集型、成本高昂的工作,容易出现癌症报告不足或错误、差异相关的差异反应。美国基于人群的中央癌症登记处识别其覆盖范围内的癌症发病情况,提供所有恶性肿瘤和良性脑及中枢神经系统肿瘤,并具有标准化的数据字段。本文描述了一种系统的开发、实施和特点,该系统旨在促进队列研究与癌症登记处之间的联系,并发布癌症登记处数据供匹配队列参与者使用。
虚拟汇总登记处-癌症链接系统(VPR-CLS)提供了一个在线系统,通过以下方式将队列与多个州癌症登记处联系起来:1)安全地将研究文件传输给登记处,2)提供优化的链接算法来生成初步匹配计数,以及 3)为与登记处匹配的队列参与者提供简化的提交和跟踪数据请求的流程和模板表格。
2022 年,VPR-CLS 启动时涵盖了 45 个登记处,覆盖了美国 95%的州人口和波多黎各。登记处已与 15 项研究(参与者人数为 14273 万至 1.09 亿)建立了联系。除了 1 项研究外,链接灵敏度均在 87.0%至 99.9%之间。许多登记处已采用了 VPR-CLS 的模板机构审查委员会-登记处应用程序(n=39)、模板数据使用协议(n=25)和中央机构审查委员会(n=16)。
VPR-CLS 显著提高了癌症结局的确定率,是确定队列研究、上市后监测和临床试验结局的首选方法。